{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:29:16Z","timestamp":1790195356743,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Cardiovascular disease (CVD) is a predominant cause of mortality. Pharmacists play an important role in secondary prevention of CVD, however, their role in cardiac rehabilitation is under-reported and services are under-utilised.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To explore the role of pharmacists in cardiac rehabilitation, the impact of their interventions on patient outcomes, and prospects of future role development.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>Databases searched were PubMed, Embase, Medline, Cochrane Library, Cumulative Index to Nursing and Allied Health Literature (CINAHL), and PsycINFO from January 2006 to October 2021. Randomised and non-randomised controlled trials were selected if they assessed the role of pharmacists in cardiac rehabilitation. Cochrane risk of bias tool, Joanna Briggs Institute (JBI) Critical Appraisal Tool for Quasi-Experimental Studies and the National Heart, Lung and Blood Institute (NIH) quality assessment tool, were used to assess quality and a narrative synthesis was conducted.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The search yielded 786 studies, only five met the inclusion criteria. The pharmacist-led interventions included patient education, medication review and reconciliation, and medication adherence encouragement. Four out of the five studies showed that pharmacist-led interventions in cardiac rehabilitation significantly improved patient clinical and non-clinical outcomes. One study showed a statistically significant reduction in low density lipoprotein-cholesterol (LDL-C) levels to optimal target of\u2009&lt;\u200970\u00a0mg\/dL (80% vs 60%,<jats:italic>p<\/jats:italic>\u2009=\u20090.0084). Two studies reported better medication adherence, and two studies showed greater improvement in all domains of health-related quality of life observed in the intervention group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Pharmacist-led interventions in cardiac rehabilitation could lower CVD risk factors and hence recurrence. Although these findings support pharmacists\u2019 involvement in cardiac rehabilitation, larger intervention studies are needed to evaluate the feasibility of pharmacist-led interventions and their impact on hospital admissions and mortality risk.<\/jats:p><\/jats:sec>","DOI":"10.1007\/s11096-022-01517-1","type":"journal-article","created":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T12:03:02Z","timestamp":1668859382000},"page":"320-329","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["A systematic review investigating the role and impact of pharmacist interventions in cardiac rehabilitation"],"prefix":"10.1007","volume":"45","author":[{"given":"Aamna","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0979-7047","authenticated-orcid":false,"given":"Ping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6126-3379","authenticated-orcid":false,"given":"Zahraa","family":"Jalal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,19]]},"reference":[{"key":"1517_CR1","unstructured":"Public Health England. Health matters: preventing cardiovascular disease. 2020. https:\/\/www.gov.uk\/government\/publications\/health-matters-preventing-cardiovascular-disease\/health-matters-preventing-cardiovascular-disease. Accessed 20 July 2022."},{"key":"1517_CR2","unstructured":"National Institute for Health and Care Excellence. Cardiac rehabilitation and secondary prevention. 2020. https:\/\/www.nice.org.uk\/guidance\/ng185\/resources\/visual-summary-secondary-prevention-pdf-8900620813. Accessed 12 Nov 2021."},{"key":"1517_CR3","unstructured":"British Heart Foundation. Cardiac Rehabilitation. 2018. https:\/\/www.bhf.org.uk\/informationsupport\/support\/practical-support\/cardiac-rehabilitation. Accessed 12 Nov 2021."},{"key":"1517_CR4","unstructured":"National Institute for Health and Care Excellence. Acute coronary syndromes. 2020. https:\/\/www.nice.org.uk\/guidance\/ng185\/chapter\/Recommendations#cardiac-rehabilitation-after-an-mi. Accessed 12 Nov 2021."},{"key":"1517_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h5000","volume":"351","author":"HM Dalal","year":"2015","unstructured":"Dalal HM, Doherty P, Taylor RS. Cardiac rehabilitation. BMJ. 2015;351: h5000.","journal-title":"BMJ"},{"key":"1517_CR6","unstructured":"National Institute for Health and Care Excellence. Chronic heart failure in adults: diagnosis and management. 2018. https:\/\/www.nice.org.uk\/guidance\/ng106\/resources\/resource-impact-report-pdf-6537494413. Accessed 12 Nov 2021."},{"issue":"1","key":"1517_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2015.10.044","volume":"67","author":"L Anderson","year":"2016","unstructured":"Anderson L, Oldridge N, Thompson DR, et al. Exercise-based cardiac rehabilitation for coronary heart disease: cochrane systematic review and meta-analysis. JACC. 2016;67(1):1\u201312.","journal-title":"JACC"},{"issue":"3","key":"1517_CR8","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.hlc.2019.03.015","volume":"29","author":"CM Astley","year":"2019","unstructured":"Astley CM, Beltrame JF, Keeh WJ, et al. The impact of cardiac rehabilitation and secondary prevention programs on 12-month clinical outcomes: a linked data analysis. Heart Lung Circ. 2019;29(3):475\u201382.","journal-title":"Heart Lung Circ"},{"key":"1517_CR9","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.ahj.2011.07.017","volume":"162","author":"PR Lawler","year":"2011","unstructured":"Lawler PR, Filion KB, Eisenberg MJ. Efficacy of exercise-based cardiac rehabilitation post-myocardial infarction: a systematic review and meta-analysis of randomized controlled trials. Am Heart J. 2011;162:571\u201384.","journal-title":"Am Heart J"},{"key":"1517_CR10","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s11897-014-0186-8","volume":"11","author":"M Casenghi","year":"2014","unstructured":"Mastromarino V, Casenghi M, Testa M, et al. Polypharmacy in heart failure patients. Curr Heart Fail Rep. 2014;11:212\u20139.","journal-title":"Curr Heart Fail Rep"},{"key":"1517_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2017-000687","volume":"5","author":"S Omboni","year":"2018","unstructured":"Omboni S, Caserini M. Effectiveness of pharmacists intervention in the management of cardiovascular diseases. Open Heart. 2018;5: e000687.","journal-title":"Open Heart"},{"issue":"15","key":"1517_CR12","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1093\/ajhp\/61.15.1593","volume":"61","author":"RT Kammer","year":"2004","unstructured":"Kammer RT. Pharmacist\u2019s role in a cardiac rehabilitation program. Am J Health Syst Pharm. 2004;61(15):1593\u20135.","journal-title":"Am J Health Syst Pharm"},{"issue":"2","key":"1517_CR13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1211\/0022357055984","volume":"13","author":"S White","year":"2005","unstructured":"White S, Anderson C. The involvement of pharmacists in cardiac rehabilitation: a review of the literature. Int J Pharm Pract. 2005;13(2):101\u20137.","journal-title":"IJPP"},{"key":"1517_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71.","journal-title":"BMJ"},{"key":"1517_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343: d5928.","journal-title":"BMJ"},{"key":"1517_CR16","unstructured":"Review Manager (RevMan) [computer program]. Version 5.4. Copenhagen. The Nordic Cochrane Centre: The Cochrane Collaboration. 2014."},{"key":"1517_CR17","unstructured":"The Joanna Briggs Institute Critical Appraisal tools for Quasi-Experimental Studies. 2019. https:\/\/jbi.global\/sites\/default\/files\/2019-05\/JBI_Quasi-Experimental_Appraisal_Tool2017_0.pdf. Accessed 12 Nov 2021."},{"key":"1517_CR18","unstructured":"The National Heart, Lung and Blood Institute Quality Assessment Tool. 2013. https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools. Accessed 12 Nov 2021."},{"key":"1517_CR19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/bcpt.13214","volume":"125","author":"EA Casper","year":"2019","unstructured":"Casper EA, El Wakeel LM, Saleh MA, et al. Management of pharmacotherapy-related problems in acute coronary syndrome: role of clinical pharmacist in cardiac rehabilitation unit. Basic Clin Pharmacol Toxicol. 2019;125:44\u201353.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"1","key":"1517_CR20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12955-016-0583-7","volume":"15","author":"L Anchah","year":"2017","unstructured":"Anchah L, Hassali MS, Lim MS, et al. Health related quality of life assessment in acute coronary syndrome patients: the effectiveness of phase I cardiac rehabilitation. Health Qual Life Outcomes. 2017;15(1):10.","journal-title":"Health Qual Life Outcomes"},{"key":"1517_CR21","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/HCR.0b013e318272bbf2","volume":"32","author":"W Alsabbagh","year":"2012","unstructured":"Alsabbagh W, Lemstra M, Eurich D, et al. Pharmacist intervention in cardiac rehabilitation; a randomised controlled trial. J Cardiopulm Rehab Prev. 2012;32:394\u20139.","journal-title":"J Cardiopulm Rehab Prev"},{"key":"1517_CR22","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/s12872-021-02178-0","volume":"21","author":"MJ \u00d6stbring","year":"2021","unstructured":"\u00d6stbring MJ, Eriksson T, Petersson G, et al. Effects of pharmaceutical care intervention on clinical outcomes and patient adherence in coronary heart disease: the MIMeRiC randomised controlled trial. BMC Cardiovasc Disord. 2021;21:367.","journal-title":"BMC Cardiovasc Disord"},{"issue":"3","key":"1517_CR23","first-page":"113","volume":"41","author":"K Packard","year":"2012","unstructured":"Packard K, Herink M, Kuhlman P, et al. Pharmacist\u2019s role in an interdisciplinary cardiac rehabilitation team. J Allied Health. 2012;41(3):113\u2013117b.","journal-title":"J Allied Health"},{"key":"1517_CR24","unstructured":"National Institute for Health and Care Excellence. Unstable angina and NSTEMI: the early management of unstable angines and non-ST-segment-elevation myocardial infarction. 2020. https:\/\/www.nice.org.uk\/guidance\/ng185\/documents\/addendum-appendicies-9. Accessed 01 Dec 2021."},{"issue":"6","key":"1517_CR25","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.ihj.2016.03.027","volume":"68","author":"KK Sharma","year":"2016","unstructured":"Sharma KK, Gupta R, Mathur M, et al. Non-physician health workers for improving adherence to medication and healthy lifestyle following acute coronary syndrome: 24-month follow-up study. Indian Heart J. 2016;68(6):832\u201340.","journal-title":"Indian Heart J"},{"issue":"7","key":"1517_CR26","first-page":"741","volume":"20","author":"EM Davis","year":"2014","unstructured":"Davis EM, Packard K, Jackevicius CA, et al. The Pharmacists role in predicting and improving medication adherence in heart failure patients. J Manag Care Spec Pharm. 2014;20(7):741\u201355.","journal-title":"J Manag Care Spec Pharm"},{"issue":"7","key":"1517_CR27","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1001\/archinte.168.7.687","volume":"168","author":"SL Koshman","year":"2008","unstructured":"Koshman SL, Charrois TL, Simpson SH, et al. Pharmacist care of patients with heart failure: a systematic review of randomized trials. Arch Intern Med. 2008;168(7):687\u201394.","journal-title":"Arch Intern Med"},{"key":"1517_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1493","volume":"374","author":"ST Simon","year":"2021","unstructured":"Simon ST, Kini V, Levy EA, et al. Medication adherence in cardiovascular medicine. BMJ. 2021;374: n1493.","journal-title":"BMJ"},{"key":"1517_CR29","first-page":"537","volume":"13","author":"D Lane","year":"2019","unstructured":"Lane D, Patel P, Kunti K, et al. Objective measures of non-adherence in cardiovascular medicine. Dovepress. 2019;13:537\u201347.","journal-title":"Dovepress"},{"issue":"5","key":"1517_CR30","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1054\/S1071-9164(03)00130-1","volume":"9","author":"ML Bouvy","year":"2003","unstructured":"Bouvy ML, Heerdink ER, Urquhart J, et al. Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: a randomized controlled study. J Card Fail. 2003;9(5):404\u201311.","journal-title":"J Card Fail"},{"issue":"4","key":"1517_CR31","first-page":"982","volume":"150","author":"FH Gwadry-Sridhar","year":"2005","unstructured":"Gwadry-Sridhar FH, Arnold JM, Zhang Y, et al. Pilot study to determine the impact of a multidisciplinary educational intervention in patients hospitalized with heart failure. Am Heart J. 2005;150(4):982.","journal-title":"Am Heart J"},{"issue":"5","key":"1517_CR32","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/jcpt.12185","volume":"39","author":"K Stewart","year":"2014","unstructured":"Stewart K, George J, Mc Namara KP, et al. A multi-faceted pharma- cist intervention to improve antihypertensive adherence: a cluster- randomized, controlled trial (HAPPy trial). J Clin Pharm Ther. 2014;39(5):527\u201334.","journal-title":"J Clin Pharm Ther"},{"issue":"1","key":"1517_CR33","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s11096-010-9474-x","volume":"33","author":"M Morgado","year":"2011","unstructured":"Morgado M, Rolo S, Castelo-Branco M. Pharmacist intervention program to enhance hypertension control: a randomised controlled trial. Int J Clin Pharm. 2011;33(1):132\u201340.","journal-title":"Int J Clin Pharm"},{"key":"1517_CR34","doi-asserted-by":"crossref","unstructured":"Fikri-Benbrahim N, Faus MJ, Mart\u00ednez-Mart\u00ednez F, et al. Impact of a community pharmacists\u2019 hypertension- care service on medication adherence. The AFenPA study. Res Soc Adm Pharm. 2013; 9(6): 797\u2013805.","DOI":"10.1016\/j.sapharm.2012.12.006"},{"issue":"2","key":"1517_CR35","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s40266-016-0429-3","volume":"34","author":"CY Lin","year":"2017","unstructured":"Lin CY, Yaseri M, Pakpour AH, et al. Can a multifaceted intervention including motivational interviewing improve medication adherence, quality of life and mortality rates in older patients undergoing coronary artery bypass surgery? A multicentre RCT Drugs Aging. 2017;34(2):143\u201356.","journal-title":"A multicentre RCT Drugs Aging"},{"key":"1517_CR36","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s11096-012-9607-5","volume":"34","author":"JV Dalem","year":"2012","unstructured":"Dalem JV, Krass I, Aslani P. Interventions promoting adherence to cardiovascular medicines. Int J Clin Pharm. 2012;34:295\u2013311.","journal-title":"International Journal of Clin Pharm"},{"key":"1517_CR37","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/MLR.0b013e3181c132ad","volume":"48","author":"DC Chan","year":"2010","unstructured":"Chan DC, Shrank WH, Cutler D, et al. Patient, physician, and payment predictors of statin adherence. Med Care. 2010;48:196\u2013202.","journal-title":"Med Care"},{"key":"1517_CR38","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.clinthera.2011.02.003","volume":"33","author":"BK Zedler","year":"2011","unstructured":"Zedler BK, Kakad P, Colilla S, et al. Does packaging with a calendar feature improve adherence to self-administered medication for long-term use? A systematic review. Clin Ther. 2011;33:62\u201373.","journal-title":"A systematic review Clinical thera"},{"key":"1517_CR39","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1345\/aph.1P281","volume":"44","author":"SR Eussen","year":"2010","unstructured":"Eussen SR, Elst ME, Klungel OH, et al. A pharmaceutical care program to improve adherence to statin therapy: a randomized controlled trial. Ann Pharmacother. 2010;44:1905\u201313.","journal-title":"Ann Pharmacother"},{"key":"1517_CR40","unstructured":"National Governors Association. The expanding role of pharmacists in a transformed health care system. 2015. https:\/\/www.nga.org\/center\/publications\/health\/the-expanding-role-of-pharmacists-in-a-transformed-health-care-system\/. Accessed 06 Dec 2021."},{"issue":"6","key":"1517_CR41","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/j.1875-9114.1997.tb03092.x","volume":"17","author":"B Carter","year":"1997","unstructured":"Carter B, Barnette D, Chrischilles E, et al. Evaluation of hypertensive patients after care provided by community pharmacists in a rural setting. Pharmacotherapy. 1997;17(6):1274\u201385.","journal-title":"Pharmacotherapy"},{"issue":"7","key":"1517_CR42","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S1086-5802(16)30099-7","volume":"NS36","author":"J Park","year":"1996","unstructured":"Park J, Kelly P, Carter B, et al. Comprehensive pharmaceutical care in the chain setting: drug therapy monitoring and counseling by pharma- cists contributed to improved blood pressure control in study patients. J Am Pharm Assoc (Wash). 1996;NS36(7):443\u201351.","journal-title":"J Am Pharm Assoc (Wash)"},{"issue":"3","key":"1517_CR43","first-page":"158","volume":"12","author":"PE Bogden","year":"1997","unstructured":"Bogden PE, Koontz LM, Williamson P, et al. The physician and pharmacist team: an effective approach to cholesterol reduction. J Gen Int Med. 1997;12(3):158\u201364.","journal-title":"J Gen Int Med"},{"issue":"2","key":"1517_CR44","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1365-2125.2005.02387.x","volume":"60","author":"A Sadik","year":"2005","unstructured":"Sadik A, Yousif M, McElnay JC. Pharmaceutical care of patients with heart failure. Br J Clin Pharmacol. 2005;60(2):183\u201393.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"1517_CR45","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/ehjcvp\/pvaa108","volume":"8","author":"SE El Hadidi","year":"2022","unstructured":"El Hadidi SE, Rosano G, Tamargo J, et al. Potentially inappropriate prescriptions in heart failure with reduced ejection fraction: ESC position statement on heart failure with reduced ejection fraction-specific inappropriate prescribing. Eur Heart J-Cardiovasc Pharmacother. 2022;8(2):187\u2013210.","journal-title":"Eur Heart J-Cardiovasc Pharmacother"},{"key":"1517_CR46","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.14457","volume":"75","author":"E Aubeeluck","year":"2021","unstructured":"Aubeeluck E, Al-Arkee S, Jalal Z, et al. The impact of pharmacy care and motivational interviewing on improving medication adherence in patients with cardiovascular diseases; a systematic review of randomised controlled trials. Int J Clin Pract. 2021;75:e14457.","journal-title":"Int J of Clin Pract"},{"issue":"5","key":"1517_CR47","doi-asserted-by":"publisher","first-page":"e895","DOI":"10.1097\/PTS.0000000000000983","volume":"18","author":"S El Hadidi","year":"2022","unstructured":"El Hadidi S, Hamdi M, Sabry N. Should pharmacists lead medication reconciliation in critical care? A one-stem interventional study in an Egyptian intensive care unit. J Patient Safe. 2022;18(5):e895\u20139.","journal-title":"J Patient Safe"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-022-01517-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-022-01517-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-022-01517-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T12:17:01Z","timestamp":1701433021000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-022-01517-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,19]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["1517"],"URL":"https:\/\/doi.org\/10.1007\/s11096-022-01517-1","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,19]]},"assertion":[{"value":"13 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}